---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-031568"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2023-09-05T23:59:59+00:00"
generated_at: "2026-06-11T00:09:28.790015+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Anebulo Pharmaceuticals' Acting CFO resigns as advisory agreement with Potrero terminated

## Summary
- Potrero Hill Advisors terminated Master Services Agreement with Anebulo effective Sept 28, 2023.
- Sandra Gardiner resigned as Acting CFO, principal financial and accounting officer, effective Sept 28.
- Gardiner offered limited transition support to successor post-termination, subject to further discussion.
- Company warns of risk to financing/accounting function if successor not found by termination date.

## SEC filing metadata
- accession: 0001493152-23-031568
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2023-09-05T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.02, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000149315223031568/0001493152-23-031568-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000149315223031568/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-031568
- JSON: https://secwatch.observer/filing/0001493152-23-031568.json
- Plain text: https://secwatch.observer/filing/0001493152-23-031568.txt

## Key facts
- Executive change
  Sandra A. Gardiner resigned as Acting Chief Financial Officer at Anebulo Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Acting Chief Financial Officer
  source text: On August 29, 2023, in connection with the termination of the Master Services Agreement, Sandra A. Gardiner notified the Company of her resignation as the Company’s Acting Chief Financial Officer, including as the Company’s principal financial officer and principal accounting officer, effective as of the Termination Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815974/000149315223031568/0001493152-23-031568-index.htm
- Material Agreements
  Anebulo Pharmaceuticals, Inc. terminated Master Services Agreement with Potrero Hill Advisors, LLC valued at Termination of Master Services Agreement effective September 28, 2023 (effective 2023-09-28).
  - Action: termination
  - Counterparty: Potrero Hill Advisors, LLC
  - Value: Termination of Master Services Agreement effective September 28, 2023
  - Effective: 2023-09-28
  source text: Item 1.02 Termination of a Material Definitive Agreement. On August 29, 2023, Potrero Hill Advisors, LLC (“Potrero”) provided written notice to terminate that certain Master Services Agreement, dated as of March 2, 2023, by and between Anebulo Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Potrero (the “Master Services Agreement”), effective as of September 28, 2023 (the “Termination Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815974/000149315223031568/0001493152-23-031568-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.